abstract |
Disclosed herein are aminopyrimidine-containing compounds that inhibit both MER tyrosine kinase (MERTK) and TYRO3 kinase activity. Further disclosed are methods of synthesizing and using aminopyrimidine-containing compounds as anticancer agents, immunostimulatory and immunomodulatory agents, platelet aggregation inhibitors, anti-infective agents, and adjuvant agents. |